Does the media favor FWDI or NAKA?

In the previous week, Forward Industries had 12 more articles in the media than KindlyMD. MarketBeat recorded 15 mentions for Forward Industries and 3 mentions for KindlyMD. Forward Industries' average media sentiment score of 0.62 beat KindlyMD's score of 0.48 indicating that Forward Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forward Industries 5 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NAKA or CEPO?

KindlyMD currently has a consensus price target of $20.00, suggesting a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Cantor Equity Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Cantor Equity Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend NAKA or BNC?

KindlyMD presently has a consensus target price of $20.00, indicating a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, equities analysts clearly believe KindlyMD is more favorable than CEA Industries. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 CEA Industries 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings & valuation, NAKA or BNC?

CEA Industries has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than CEA Industries, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 90.39 -$52.23M -$35.85 N/A CEA Industries $27.99M 8.99 $115.26M $5.53 1.10

Is NAKA or BNC more profitable?

CEA Industries has a net margin of 362.26% compared to KindlyMD's net margin of -1,067.93%. CEA Industries' return on equity of 64.29% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% CEA Industries 362.26% 64.29% 54.03%

Does the media refer more to NAKA or BNC?

In the previous week, KindlyMD had 1 more articles in the media than CEA Industries. MarketBeat recorded 3 mentions for KindlyMD and 2 mentions for CEA Industries. CEA Industries' average media sentiment score of 1.15 beat KindlyMD's score of 0.48 indicating that CEA Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CEA Industries 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NAKA or MAAS?

KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, research analysts clearly believe KindlyMD is more favorable than Maase. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Maase 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, NAKA or MAAS?

Maase has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 90.39 -$52.23M -$35.85 N/A Maase $109.05M 2.20 -$27.36M N/A N/A

Is NAKA or MAAS more profitable?

Maase has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Maase's return on equity of 0.00% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% Maase N/A N/A N/A

Does the media favor NAKA or MAAS?

In the previous week, KindlyMD had 1 more articles in the media than Maase. MarketBeat recorded 3 mentions for KindlyMD and 2 mentions for Maase. KindlyMD's average media sentiment score of 0.48 beat Maase's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Maase 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

KindlyMD (NAKA) Competitors

$9.19 -0.68 (-6.89%)

As of 09/23/2026 04:00 PM Eastern

Compare

NAKA vs. FWDI, ACTG, CEPO, BNC, and MAAS

Should you buy KindlyMD stock or one of its competitors? KindlyMD's main competitors and comparable companies include Forward Industries (FWDI), Acacia Research (ACTG), Cantor Equity Partners (CEPO), CEA Industries (BNC), and Maase (MAAS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does KindlyMD compare to Forward Industries?

Forward Industries (NASDAQ:FWDI) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

KindlyMD has lower revenue, but higher earnings than Forward Industries. KindlyMD is trading at a lower price-to-earnings ratio than Forward Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forward Industries	$18.19M	32.72	-$166.97M	$0.12	67.17
KindlyMD	$1.82M	90.39	-$52.23M	-$35.85	N/A

KindlyMD has a net margin of -1,067.93% compared to Forward Industries' net margin of -2,073.82%. Forward Industries' return on equity of -18.05% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forward Industries	-2,073.82%	-18.05%	-17.03%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Forward Industries has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.99, meaning that its share price is 1,499% more volatile than the broader market.

In the previous week, Forward Industries had 12 more articles in the media than KindlyMD. MarketBeat recorded 15 mentions for Forward Industries and 3 mentions for KindlyMD. Forward Industries' average media sentiment score of 0.62 beat KindlyMD's score of 0.48 indicating that Forward Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Forward Industries	5 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Forward Industries currently has a consensus target price of $13.50, suggesting a potential upside of 67.49%. KindlyMD has a consensus target price of $20.00, suggesting a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Forward Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forward Industries	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Forward Industries and KindlyMD tied by winning 7 of the 14 factors compared between the two stocks.

How does KindlyMD compare to Acacia Research?

KindlyMD (NASDAQ:NAKA) and Acacia Research (NASDAQ:ACTG) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Acacia Research has higher revenue and earnings than KindlyMD. Acacia Research is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	90.39	-$52.23M	-$35.85	N/A
Acacia Research	$285.23M	1.48	$21.68M	-$0.15	N/A

86.7% of Acacia Research shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by insiders. Comparatively, 1.7% of Acacia Research shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

KindlyMD currently has a consensus price target of $20.00, indicating a potential upside of 117.63%. Acacia Research has a consensus price target of $6.00, indicating a potential upside of 38.89%. Given KindlyMD's stronger consensus rating and higher probable upside, research analysts plainly believe KindlyMD is more favorable than Acacia Research.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Acacia Research	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Acacia Research has a net margin of -5.39% compared to KindlyMD's net margin of -1,067.93%. Acacia Research's return on equity of 0.44% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Acacia Research	-5.39%	0.44%	0.33%

In the previous week, KindlyMD had 3 more articles in the media than Acacia Research. MarketBeat recorded 3 mentions for KindlyMD and 0 mentions for Acacia Research. KindlyMD's average media sentiment score of 0.48 beat Acacia Research's score of -0.06 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Neutral
Acacia Research	Neutral

KindlyMD has a beta of 15.99, indicating that its share price is 1,499% more volatile than the broader market. Comparatively, Acacia Research has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Summary

KindlyMD beats Acacia Research on 9 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Cantor Equity Partners?

KindlyMD (NASDAQ:NAKA) and Cantor Equity Partners (NASDAQ:CEPO) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

Cantor Equity Partners has lower revenue, but higher earnings than KindlyMD. Cantor Equity Partners is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	90.39	-$52.23M	-$35.85	N/A
Cantor Equity Partners	N/A	N/A	-$6.66M	-$0.29	N/A

Cantor Equity Partners has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Cantor Equity Partners' return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Cantor Equity Partners	N/A	N/A	-0.74%

KindlyMD currently has a consensus price target of $20.00, suggesting a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Cantor Equity Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Cantor Equity Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, KindlyMD had 3 more articles in the media than Cantor Equity Partners. MarketBeat recorded 3 mentions for KindlyMD and 0 mentions for Cantor Equity Partners. KindlyMD's average media sentiment score of 0.48 beat Cantor Equity Partners' score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Neutral
Cantor Equity Partners	Neutral

KindlyMD has a beta of 15.99, suggesting that its share price is 1,499% more volatile than the broader market. Comparatively, Cantor Equity Partners has a beta of -0.05, suggesting that its share price is 105% less volatile than the broader market.

Summary

KindlyMD beats Cantor Equity Partners on 8 of the 13 factors compared between the two stocks.

How does KindlyMD compare to CEA Industries?

KindlyMD (NASDAQ:NAKA) and CEA Industries (NASDAQ:BNC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

KindlyMD has a beta of 15.99, suggesting that its share price is 1,499% more volatile than the broader market. Comparatively, CEA Industries has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

CEA Industries has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than CEA Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	90.39	-$52.23M	-$35.85	N/A
CEA Industries	$27.99M	8.99	$115.26M	$5.53	1.10

KindlyMD presently has a consensus target price of $20.00, indicating a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, equities analysts clearly believe KindlyMD is more favorable than CEA Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CEA Industries	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

CEA Industries has a net margin of 362.26% compared to KindlyMD's net margin of -1,067.93%. CEA Industries' return on equity of 64.29% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
CEA Industries	362.26%	64.29%	54.03%

In the previous week, KindlyMD had 1 more articles in the media than CEA Industries. MarketBeat recorded 3 mentions for KindlyMD and 2 mentions for CEA Industries. CEA Industries' average media sentiment score of 1.15 beat KindlyMD's score of 0.48 indicating that CEA Industries is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CEA Industries	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CEA Industries beats KindlyMD on 8 of the 14 factors compared between the two stocks.

How does KindlyMD compare to Maase?

KindlyMD (NASDAQ:NAKA) and Maase (NASDAQ:MAAS) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Maase has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Maase's return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Maase	N/A	N/A	N/A

KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 117.63%. Given KindlyMD's stronger consensus rating and higher probable upside, research analysts clearly believe KindlyMD is more favorable than Maase.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Maase	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, KindlyMD had 1 more articles in the media than Maase. MarketBeat recorded 3 mentions for KindlyMD and 2 mentions for Maase. KindlyMD's average media sentiment score of 0.48 beat Maase's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Maase	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

KindlyMD has a beta of 15.99, suggesting that its stock price is 1,499% more volatile than the broader market. Comparatively, Maase has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

Maase has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	90.39	-$52.23M	-$35.85	N/A
Maase	$109.05M	2.20	-$27.36M	N/A	N/A

Summary

KindlyMD beats Maase on 7 of the 12 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$176.62M	$27.39B	$13.77B	$13.29B
Dividend Yield	N/A	6.72%	5.95%	12.57%
P/E Ratio	-0.26	19.34	25.23	25.69
Price / Sales	90.39	425.22	518.36	93.60
Price / Cash	N/A	254.09	46.12	52.76
Price / Book	0.20	3.15	2.71	6.32
Net Income	-$52.23M	$1.10B	$1.31B	$359.73M
7 Day Performance	12.07%	2.63%	0.06%	1.35%
1 Month Performance	30.17%	10.74%	-0.79%	-3.68%
1 Year Performance	-81.62%	-2.06%	8.58%	5.56%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	3.9593 of 5 stars	$9.19 -6.9%	$20.00 +117.6%	-81.6%	$176.62M	$1.82M	N/A	N/A	News Coverage Analyst Forecast
FWDI Forward Industries	2.9267 of 5 stars	$8.06 -6.3%	$13.50 +67.5%	N/A	$595.23M	$18.19M	67.17	60	News Coverage Analyst Forecast Options Volume Gap Down High Trading Volume
ACTG Acacia Research	1.6437 of 5 stars	$4.32 -0.5%	$6.00 +38.9%	+31.7%	$421.59M	$285.23M	N/A	986
CEPO Cantor Equity Partners	N/A	$10.76 -0.3%	N/A	+2.5%	$274.38M	N/A	N/A	2
BNC CEA Industries	1.3695 of 5 stars	$6.11 -3.6%	N/A	N/A	$251.55M	$29.33M	1.10	164	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors

NAKA vs. FWDI, ACTG, CEPO, BNC, and MAAS

How does KindlyMD compare to Forward Industries?

Summary

How does KindlyMD compare to Acacia Research?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Summary

How does KindlyMD compare to CEA Industries?

Summary

How does KindlyMD compare to Maase?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KindlyMD (NAKA) Competitors

NAKA vs. FWDI, ACTG, CEPO, BNC, and MAAS

How does KindlyMD compare to Forward Industries?

Which has better earnings & valuation, FWDI or NAKA?

Is FWDI or NAKA more profitable?

Which has more volatility and risk, FWDI or NAKA?

Does the media favor FWDI or NAKA?

Do analysts rate FWDI or NAKA?

Summary

How does KindlyMD compare to Acacia Research?

Which has stronger earnings & valuation, NAKA or ACTG?

Do institutionals and insiders have more ownership in NAKA or ACTG?

Do analysts recommend NAKA or ACTG?

Is NAKA or ACTG more profitable?

Does the media favor NAKA or ACTG?

Which has more risk & volatility, NAKA or ACTG?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Which has higher earnings & valuation, NAKA or CEPO?

Is NAKA or CEPO more profitable?

Do analysts recommend NAKA or CEPO?

Does the media prefer NAKA or CEPO?

Which has more volatility & risk, NAKA or CEPO?

Summary

How does KindlyMD compare to CEA Industries?

Which has more volatility and risk, NAKA or BNC?

Which has stronger earnings & valuation, NAKA or BNC?

Do analysts recommend NAKA or BNC?

Is NAKA or BNC more profitable?

Does the media refer more to NAKA or BNC?

Summary

How does KindlyMD compare to Maase?

Is NAKA or MAAS more profitable?

Do analysts recommend NAKA or MAAS?

Does the media favor NAKA or MAAS?

Which has more risk & volatility, NAKA or MAAS?

Which has better earnings & valuation, NAKA or MAAS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools